Earnings

Dyne Therapeutics narrows Q4 loss to $0.73/share vs $0.76 estimate, shares jump 11.8% on improving trajectory and $893M cash position.

BioNTech posts wider-than-expected Q4 loss of $0.33/share as COVID vaccine revenue plunges 24% year-over-year; founders to exit for new mRNA…

Sprinklr Inc (CXM) delivered Q4 2025 adjusted earnings of $0.10 per share, surpassing analysts' $0.09 forecast (beat by 10.0%). Top-line…

**Broadwind Energy Inc Reports Q4 2025 Results**

**ATRenew Inc Reports Q4 2025 Results**

Pangaea Logistics Solutions Ltd (PANL) turned in Q4 2025 gaap EPS of $0.18, undershooting the $0.23 Street estimate (miss by…

SolarEdge narrows Q4 loss to $0.14/share vs $0.24 estimate, stock jumps 10% despite cautious Q1 guidance of $290M-$320M revenue.

Groupon Inc (GRPN) posted Q4 2025 gaap EPS of $0.17, falling short of the $0.50 estimate (miss by 66.0%). Top-line…

CRISPR Therapeutics posts wider-than-expected Q4 loss of $1.37/share on zero revenue; shares sink 10% as cash burn accelerates.

**Cadre Holdings Reports Q4 2025 Earnings Miss**